Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |